-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Maintains Buy on DexCom, Raises Price Target to $82

Benzinga·07/31/2026 13:29:29
语音播报
Benchmark analyst Bruce D. Jackson maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $77 to $82.